TTK Healthcare valuation

·OthersChart ›
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
5.01×————
1.03×————
1.51×————
Enterprise multiples
1.44×————
35.99×————
47.13×————
Yield
20.0%————
−1.9%————
Reference — adjusted share basis
₹980.00————
₹195.71₹46.48₹57.79₹44.47₹452.72
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

TTKHLTCARE₹980.00

TTK Healthcare Limited

· Others
₹ CrorePeersDCMSHRIRAMBALMLAWRIEGODREJIND3MINDIAMcap ₹1,385 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————5.01
P/B————1.03
P/Sales————1.51
Enterprise Multiples
EV/Sales————1.44
EV/EBITDA————35.99
EV/EBIT————47.13
Yield
Earnings Yield %————19.97
FCF Yield %————-1.95
Reference — adjusted share basis
Price (FY-end close, adj.)————980.00
EPS (adj.)452.7244.4757.7946.48195.71
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.